Morphosys (MOR) has released an update.
MorphoSys AG has announced a significant change in its shareholding structure, with Morgan Stanley now holding a total of 11.51% of the company’s voting rights after recent transactions. This change, which includes a mix of direct shares and financial instruments such as equity swaps and options, crossed the notification threshold on 09 May 2024. The company made the announcement in compliance with German securities trading law, aiming for broad European distribution of this information.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
